| Bioactivity | SSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2) [1]. |
| Target | SARS-CoV |
| Name | SSAA09E2 |
| CAS | 883944-52-3 |
| Formula | C16H20N4O2 |
| Molar Mass | 300.36 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Bibi N, et al. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. Eur J Pharmacol. 2020;885:173496. |
SSAA09E2
CAS: 883944-52-3 F: C16H20N4O2 W: 300.36
SSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking ear
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.